Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    21094089 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Conditions: Chronic Lymphoid Leukemia;   Lymphoid Malignancies;   Non-Hodgkin's Lymphoma;   Follicular Lymphoma;   Mantle Cell Lymphoma;   Peripheral T-cell Lymphoma
Intervention: Drug: ABT-263

Study has passed its completion date and status has not been verified in more than two years.